Ask AI
CLL BTK Inhibitor Tx and AE Guide

CME

Global Perspectives and Clinical Resources to Guide Treatment Decisions and Management of Adverse Events With BTK Inhibitor Therapy in CLL 

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Released: March 13, 2025

Expiration: September 12, 2025

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Currently, which of the following BTK inhibitors has/have an approved indication in combination with venetoclax?